Latest Press Releases
View all
TimeHeadline
23m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
56m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
56m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
56m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
56m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Karyopharm Therapeutics Inc logo

Karyopharm Therapeutics Inc

About

Karyopharm Therapeutics Inc (NASDAQ:KPTI) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 24 2026
Karyopharm Announces $30 Million Private Placement with RA Capital
Mar 24 2026
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Feb 12 2026
Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Feb 5 2026
Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Feb 2 2026
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financials

Revenue
$146.07 M
Market Cap
$142.47 M
EPS
-17.93

Community Chat

Ask AI

6ix6ixAIEvents